GO:0015807 L-amino acid transport: Genes & Research

L-amino acid transport (GO:0015807) is the biological process by which L-enantiomer amino acids are moved across cellular membranes, either into, out of, or within cells, or between cells, through the action of transporters or pores. This process is fundamental to nutrient acquisition, metabolic homeostasis, and cell signaling, as amino acids serve both as building blocks for protein synthesis and as signaling molecules that regulate pathways such as mTORC1. The directed movement of L-amino acids is mediated by a diverse array of transporter proteins, often organized as heteromeric complexes, such as the system y+L/4F2hc and system L (LAT1/4F2hc) complexes. Researchers study L-amino acid transport because it underpins essential physiological functions across tissues. In the placenta, amino acid transport capacity directly influences fetal growth and development, and is altered by environmental factors such as high altitude and glucocorticoid exposure. In the intestine, the system L transporter LAT1 (SLC7A5) is required for epithelial homeostasis, highlighting its role in tissue renewal. In T-cell malignancies, amino acid transport is reprogrammed to support the metabolic demands of rapid proliferation. Furthermore, L-amino acid transporters are exploited for diagnostic imaging and targeted therapy, as exemplified by LAT1-mediated accumulation of 4-borono-2-18F-fluoro-phenylalanine in tumors. The molecular mechanisms of L-amino acid transport have been illuminated by structural and biochemical studies. The human system y+L transporter complex has been resolved structurally, revealing how it recognizes and translocates specific amino acids. The heteromultimeric nature of system y+L/4F2hc was established through biochemical characterization. Additionally, bacterial periplasmic solute-binding proteins that bind L-amino acid amides provide evolutionary and mechanistic insights into amino acid recognition. Together, these studies define L-amino acid transport as a central node in cellular physiology with broad implications for human health and disease.

GO:0015807 (L-amino acid transport) is defined as the directed movement of L-enantiomer amino acids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the translocation of L-amino acids across biological membranes, driven by transport proteins that may function through facilitated diffusion, active transport, or exchange mechanisms.

L-amino acid transport is critically important because it controls the availability of amino acids for protein synthesis, energy metabolism, and signaling, thereby influencing fundamental cellular decisions such as growth, proliferation, and survival. In multicellular organisms, this process mediates nutrient exchange between maternal and fetal circulations, maintains intestinal barrier function, and supports immune cell activation. Dysregulation of L-amino acid transport contributes to cancer progression, fetal growth restriction, and metabolic diseases, making it a target for diagnostic and therapeutic interventions.

The following genes encode transporters, chaperones, and regulatory proteins that directly participate in or regulate L-amino acid transport (GO:0015807).

L-amino acid transport is regulated at multiple levels, including transcriptional control, post-translational modifications, and environmental cues. High altitude exposure alters placental amino acid transport, suggesting oxygen availability as a regulatory factor. Glucocorticoids regulate amino acid transport in primary human trophoblast cells, indicating hormonal control. In T-cell malignancy, amino acid transport is coordinated with metabolic reprogramming, likely through signaling pathways such as mTORC1 that sense amino acid availability. Additionally, the heteromeric assembly of transporter complexes, such as system y+L/4F2hc, is essential for their function and may be subject to regulation.

Dysregulated L-amino acid transport supports the metabolic demands of cancer cells. In T-cell malignancy, amino acid transport is reprogrammed to coordinate with metabolic pathways that fuel proliferation. LAT1 (SLC7A5) expression correlates with increased accumulation of radiolabeled amino acid analogs in tumors, enabling diagnostic imaging. Targeting amino acid transporters is therefore a promising therapeutic strategy in oncology.

Proper L-amino acid transport across the placenta is essential for fetal growth. High altitude exposure alters human placental amino acid transport, which may contribute to fetal growth restriction. Glucocorticoids regulate amino acid transport in trophoblast cells, providing a mechanism by which maternal stress could impact fetal development. These findings link L-amino acid transport to pregnancy complications.

LAT1 (SLC7A5) is required for mouse intestinal epithelial homeostasis, highlighting the importance of L-amino acid transport in tissue renewal. Disruption of this process could contribute to intestinal disorders characterized by impaired epithelial regeneration. Understanding the role of LAT1 in the intestine may inform treatments for inflammatory bowel diseases and other gastrointestinal conditions.

Radiolabeled or fluorescent amino acid uptake assays are used to measure transport activity directly. These assays can quantify the rate of L-amino acid influx or efflux in cells expressing specific transporters, and are often performed with competitive inhibitors to determine substrate specificity.

Cryo-electron microscopy and X-ray crystallography provide high-resolution structures of transporter complexes, revealing substrate binding pockets and conformational changes. The human system y+L transporter complex structure was solved using such approaches.

RNA-seq and quantitative PCR are used to measure expression levels of amino acid transporter genes across tissues and conditions. Immunohistochemistry and western blotting detect protein expression and localization, as shown for LAT1 in intestinal epithelium and in tumors.

CRISPR-Cas9 knockout, knock-in, and overexpression models enable causal testing of transporter function. For example, knockout of SLC7A5 in mice demonstrated its requirement for intestinal homeostasis, and genetic screens have identified amino acid transporters critical for T-cell malignancy.

Researchers studying L-amino acid transport-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional interrogation of L-amino acid transport genes.

L-amino acid transport (GO:0015807) is a fundamental biological process that governs amino acid availability for protein synthesis, metabolism, and signaling. Its dysregulation is implicated in cancer, placental dysfunction, and intestinal disorders, making it a critical area of research. Advances in structural biology and CRISPR-based functional genomics continue to illuminate the mechanisms and therapeutic potential of targeting L-amino acid transporters. EDITGENE offers comprehensive CRISPR services to support researchers in dissecting the roles of L-amino acid transport genes, from knockout and knock-in models to library screening and bioinformatics, accelerating discoveries that could translate into new diagnostics and treatments.